Hospitalizations less likely among older patients with IBD on Entyvio



Older patients with inflammatory bowel disease who initiate Entyvio therapy had lower risk for hospitalization than those treated with anti-TNF, according to research presented at the Crohn’s and Colitis Congress.
Bharati Kochar, MD, from Massachusetts General Hospital, said that while older adults make up a large portion of patients with IBD in the United States, they are not well represented in clinical trials.
“While more than a quarter of Americans with IBD are older than 65, less than 1% of adults in clinical trials of approved IBD therapies are 65 years or older,” she

Source link

Comments are closed, but trackbacks and pingbacks are open.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy